A polytherapy approach demonstrates therapeutic efficacy for the treatment of SOD1 associated amyotrophic lateral sclerosis
This work was supported by a FightMND Drug Development Grant, an Australian National Health and Medical Research Council (NHMRC) Investigator Grant (No. 1194872) and a Motor Neuron Disease Research Institute of Australia Bill Gole Postdoctoral Fellowship.
Authors
- Florian Dux (ORCID: https://orcid.org/0000-0002-3275-710X)
- Peter J. Crouch (ORCID: https://orcid.org/0000-0002-7777-4747)
- Rachael Bartlett (ORCID: https://orcid.org/0000-0002-9199-1326)
- Luke McAlary (ORCID: https://orcid.org/0000-0002-1764-3809)
- Christen G. Chisholm (ORCID: https://orcid.org/0000-0002-3057-7113)
- Mikayla Brown (ORCID: https://orcid.org/0000-0002-3464-3480)
- Lachlan E. McInnes
- Justin J. Yerbury (ORCID: https://orcid.org/0000-0003-2528-7039)
- Anthony Dosseto (ORCID: https://orcid.org/0000-0002-3575-0106)
- Heath Ecroyd (ORCID: https://orcid.org/0000-0001-7574-0044)
- Jeremy S. Lum (ORCID: https://orcid.org/0000-0002-2133-9308)
- Jody Gorman (ORCID: https://orcid.org/0000-0001-9824-4203)
- Natalie E. Farrawell (ORCID: https://orcid.org/0000-0001-8060-4629)
- P.S. Donnelly
Institutions
- The University of Melbourne (AU)
- University of Wollongong (AU)
Publication Details
- Journal
- EBioMedicine
- Published
- 2025-04-12
- DOI
- https://doi.org/10.1016/j.ebiom.2025.105692
- Citations
- 1
- Primary Topic
- Amyotrophic Lateral Sclerosis Research
- Type
- article
- Field-Weighted Citation Impact
- 1.39